KFSH links AI, robotic surgery and research across cardiac care

King Faisal Specialist Hospital and Research Centre says it has built a connected cardiac care pathway in Riyadh that uses AI, emergency care, robotic surgery and clinical research from arrival through recovery. The hospital says the approach is cutting treatment delays, expanding options for advanced heart failure and widening access to trials.

Why it matters: - KFSH is trying to make cardiac care move faster from triage to treatment to follow-up. - The hospital says the connected pathway reduces delays at each stage and gives patients more options when standard care is no longer enough. - The model also links routine care with research, which can widen access to investigational treatment for eligible patients.

What happened: - King Faisal Specialist Hospital and Research Centre in Riyadh said it is connecting artificial intelligence, emergency care, robotic surgery and clinical research along the cardiac patient journey. - The Patient Flow and Capacity Command Centre uses AI to forecast Emergency Department demand up to 24 hours ahead. - The hospital says time from arrival to physician assessment has fallen by around 42%. - For heart attack patients, KFSH operates a dedicated cardiac catheterization lab inside the Emergency Department. - KFSH says that setup has halved the time between arrival and reopening a blocked artery. - The hospital says the pathway makes KFSH Saudi Arabia’s only accredited Chest Pain Center with PCI. - KFSH says it performed the world’s first fully robotic heart transplant in 2024. - KFSH says it also completed the world’s first robotic-assisted implantation of a HeartMate 3 heart pump in 2025.

The details: - The hospital says ventricular assist devices and extracorporeal membrane oxygenation support critically ill patients within specialist treatment pathways. - In a center analysis of 130 recipients of an implantable pressure sensor who completed six months of follow-up, admissions for decompensated heart failure fell by 46.4%. - A round-the-clock virtual cardiac service handles urgent concerns after patients return home. - KFSH says it conducted nearly half of the clinical trials registered in Saudi Arabia during the first half of 2025. - The hospital says eligible patients can access investigational treatments under independent ethical and regulatory oversight. - KFSH says the broader goal is to make innovation function as a connected journey rather than separate achievements.

Between the lines: - The strategy suggests KFSH is positioning cardiac care as an integrated system, not a series of isolated specialty services. - The emphasis on AI forecasting, in-ED intervention and home follow-up points to a push to reduce bottlenecks and readmissions. - The trial activity also signals that the hospital wants research to be part of everyday clinical care, not a separate track.

What's next: - KFSH says patients should continue to benefit from each capability at the moment they need it. - The hospital’s next impact will likely depend on whether the connected pathway keeps improving speed, outcomes and access as volume grows. - KFSH also highlighted its 2026 rankings, which may support further expansion of its regional and global profile.

The bottom line: - KFSH is turning advanced cardiac care into a single linked pathway, with AI, robotics and research all aimed at faster treatment and broader access.